Cargando…

New method for discrimination of multiple primary lung cancer and metastatic lung cancer

Detalles Bibliográficos
Autores principales:	Shen, Cheng, Yuan, Yong, Che, Guowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715886/ https://www.ncbi.nlm.nih.gov/pubmed/36288456 http://dx.doi.org/10.1111/1759-7714.14700

Ejemplares similares

“Unique trend” and “contradictory trend” in discrimination of primary synchronous lung cancer and metastatic lung cancer
por: Shen, Cheng, et al.
Publicado: (2013)

New relationship of E2F1 and BNIP3 with caveolin‐1 in lung cancer‐associated fibroblasts
por: Shen, Cheng, et al.
Publicado: (2020)

Mutational analysis of multiple lung cancers: Discrimination between primary and metastatic lung cancers by genomic profile
por: Goto, Taichiro, et al.
Publicado: (2017)

A novel differential diagnostic model for multiple primary lung cancer: Differentially-expressed gene analysis of multiple primary lung cancer and intrapulmonary metastasis
por: CHEN, DALI, et al.
Publicado: (2015)

Method for discriminating synchronous multiple lung cancers of the same histological type: miRNA expression analysis
por: Zhou, Xudong, et al.
Publicado: (2016)

“Different trend” in multiple primary lung cancer and intrapulmonary metastasis
por: Shen, Cheng, et al.
Publicado: (2015)

COVID-19: the use of immunotherapy in metastatic lung cancer
por: Davis, Alexander P, et al.
Publicado: (2020)

Tubeless minimally invasive treatment: taking a new step in enhanced recovery after surgery (ERAS)
por: Shen, Cheng, et al.
Publicado: (2019)

Primary Lung Cancer After Treatment for Breast Cancer
por: Long, Qian, et al.
Publicado: (2021)

Towards the molecular era of discriminating multiple lung cancers
por: Wang, Ziyang, et al.
Publicado: (2023)

Multiple primary lung cancer versus intrapulmonary metastatic cancer: A case of multiple pulmonary nodules
por: Liu, Chunquan, et al.
Publicado: (2018)

Discrimination Between Primary Lung Cancer and Lung Metastases by Genomic Profiling
por: Higuchi, Rumi, et al.
Publicado: (2021)

Prognostic value of biomarkers in primary small cell carcinoma of the esophagus
por: Wang, Yan, et al.
Publicado: (2020)

Prognostic value of let-7 in lung cancer: systematic review and meta-analysis
por: Shen, Cheng, et al.
Publicado: (2020)

Commentary: Expanding the Surgical Indications in Lung Cancer
por: Park, Seong Yong
Publicado: (2023)

Immunological barriers to immunotherapy in primary and metastatic breast cancer
por: De Martino, Mara, et al.
Publicado: (2021)

Met in lung cancer
por: Dent, Paul
Publicado: (2014)

A rare case of primary peripheral epithelial myoepithelial carcinoma of lung: Case report and literature review
por: Shen, Cheng, et al.
Publicado: (2016)

Thoracic day surgery versus thoracic inpatient surgery for treatment of patients with lung cancer: a systematic review and meta-analysis
por: Shen, Cheng, et al.
Publicado: (2023)

Prognostic Characteristics of Operated Breast Cancer Patients with Second Primary Lung Cancer: A Retrospective Study
por: Wang, Yan, et al.
Publicado: (2021)

Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2016)

Silibinin: A New Opportunity for the Treatment of Brain Metastasis from Lung Cancer
por: Addeo, Raffaele
Publicado: (2021)

Lung cancer screening—Marching along …
por: Fong, Kwun M., et al.
Publicado: (2022)

ALKing the flames of lung cancer immunosensitivity
por: Bayliss, Richard, et al.
Publicado: (2023)

Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail
por: Cali Daylan, Ayse Ece, et al.
Publicado: (2023)

Checkpoint inhibitors are a basic science‐based, transformative new treatment for lung cancer
por: Miller, Alistair R.
Publicado: (2022)

Case Report: Combined Small Cell Lung Carcinoma With Pulmonary Adenocarcinoma
por: Shen, Cheng, et al.
Publicado: (2022)

Mucoid impaction mimicking multiple metastatic lung cancer
por: Huang, Yi-Chih, et al.
Publicado: (2020)

EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
por: Le, Xiuning, et al.
Publicado: (2023)

Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer
por: Basu Roy, Upal, et al.
Publicado: (2021)

Differential diagnosis of multiple primary lung cancers and intra-lung metastasis of lung cancer by multiple gene detection
por: Xu, Liuyang, et al.
Publicado: (2022)

The KEYNOTE-189 trial as a new paradigm making cure a reality for metastatic non-squamous non-small cell lung cancer
por: Wang, Yanye, et al.
Publicado: (2020)

New potential targeted strategies in small cell lung cancer
por: de Toro, María, et al.
Publicado: (2023)

Tumor Immune Microenvironment and Immunotherapy in Non-Small Cell Lung Cancer: Update and New Challenges
por: Xing, Shuqin, et al.
Publicado: (2022)

Commentary: Lung cancer resections during the pandemic
por: Shenoy, Rohit, et al.
Publicado: (2022)

The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy
por: Visconti, Roberta, et al.
Publicado: (2017)

Statins as Inhibitors of Lung Cancer Bone Metastasis
por: Sarkar, Devanand
Publicado: (2017)

Peeking inside the sphingolipid network in lung cancer
por: Canals, Daniel
Publicado: (2021)

A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
por: Liao, Che-Chi, et al.
Publicado: (2020)

International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
por: Pagani, Olivia, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2kkfdljpulkq5o9a719np1qjm8